<DOC>
	<DOCNO>NCT00035893</DOCNO>
	<brief_summary>This open-label , prospective , randomize , control study safety efficacy include clinical , immunologic , virologic assessment add Ampligen Strategic Therapeutic Intervention ( STI ) HAART patient plasma HIV RNA &lt; 50 copies/ml ( PCR ) CD4 level &gt; 400 .</brief_summary>
	<brief_title>The Role Ampligen Strategic Therapeutic Intervention ( STI ) HAART</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Poly I-C</mesh_term>
	<mesh_term>poly ( I ) .poly ( c12 , U )</mesh_term>
	<criteria>1 . Adults least 18 year age . 2 . CD4 cell count &gt; 400 cell . 3 . Plasma HIV1 RNA &lt; 50 copies/ml two occasion : one within six week prior start Baseline Baseline . 4 . History virologic success suppression HIV RNA level &lt; 50 copies/ml last nine month document minimum two time last ten month minimum three time last fifteen month patient receive HAART regiment . During four month prior start Baseline , continue Baseline 64 week study period , HAART regimen must remain unchanged contain least one follow ten antiretroviral drug : Abacavir ( Ziagen ) Zidovudine ( Retrovir ) AZT Zalcitabine ( Hivid ) ddC Didanosine ( Videx ) ddl Stavudine ( Zerit ) d4T Efavirenz ( Sustiva ) Indinavir ( Crixivan ) Ritonavir ( Norvir ) Nelfinavir ( Viracept ) Amprenavir ( Agenerase ) Only one HIV plasma RNA level &gt; 50 , &lt; 100 copies/ml permit four month period immediately prior start Baseline . 5 . Karnofsky performance status least 70 . 6 . The following laboratory parameter within 21 day prior treatment : Hemoglobin &gt; 9.2 g/dL men &gt; 8.9 g/dL woman ; Neutrophil count &gt; 1000 ; Platelet count &gt; 75,000 ; AST/ALT &lt; 4.0 x upper limit normal ( ULN ) ; Serum creatinine &lt; 1.5 x ULN creatinine clearance &gt; 50 mL/min . 7 . Ability willingness give write informed consent . 8 . For female child bear potential : A negative serum pregnancy test within 14 day prior randomization . Females child bear potential agree use effective mean contraception . 9 . The patient must complete elective routine immunization ( include influenza vaccination ) eight week prior first dose study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>treatment interruption</keyword>
	<keyword>HIV Infections</keyword>
</DOC>